| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Activity of a specific inhibitor, gefitinib (Iressa™, ZD1839), of epidermal growth factor receptor in refractory non-small-cell lung cancer
|
Santoro, A.
|
|
|
15 |
1 |
p. 33-37
|
artikel
|
| 2 |
Adoptive transfer of allogeneic Epstein–Barr virus (EBV)-specific cytotoxic T cells with in vitro antitumor activity boostsLMP2-specific immune response in a patient with EBV-related nasopharyngeal carcinoma
|
Comoli, P.
|
|
|
15 |
1 |
p. 113-117
|
artikel
|
| 3 |
A little citadel of light in a malignant sea of darkness
|
Kerr, D.
|
|
|
15 |
1 |
p. 1-2
|
artikel
|
| 4 |
Allogeneic Stem Cell Transplantation; Clinical Research and Practice
|
Schouten, H.C.
|
|
|
15 |
1 |
p. 179
|
artikel
|
| 5 |
Analysis of dihydrofolate reductase and reduced folate carrier gene status in relation to methotrexate resistance in osteosarcoma cells
|
Serra, M.
|
|
|
15 |
1 |
p. 151-160
|
artikel
|
| 6 |
Anthracyclines during pregnancy: embryo–fetal outcome in 160 patients
|
Germann, N.
|
|
|
15 |
1 |
p. 146-150
|
artikel
|
| 7 |
A phase II study of cisplatin and docetaxel administered as three consecutive weekly infusions for advanced non-small-cell lung cancer in elderly patients
|
Ohe, Y.
|
|
|
15 |
1 |
p. 45-50
|
artikel
|
| 8 |
Cancer of the skin: a forgotten problem in Europe
|
Boyle, Peter
|
|
|
15 |
1 |
p. 5-6
|
artikel
|
| 9 |
Combination therapy of Thalidomide and Peginterferon in patients with progressive multiple myeloma
|
Kasper, B.
|
|
|
15 |
1 |
p. 176-177
|
artikel
|
| 10 |
Continuous infusion of hepatic arterial irinotecan in pretreated patients with colorectal cancer metastatic to the liver
|
van Riel, J.M.G.H.
|
|
|
15 |
1 |
p. 59-63
|
artikel
|
| 11 |
Dose-dense regimen of temozolomide given every other week in patients with primary central nervous system tumors
|
Vera, K.
|
|
|
15 |
1 |
p. 161-171
|
artikel
|
| 12 |
Effect of re-treatment with gefitinib (‘Iressa’, ZD1839) after acquisition of resistance
|
Kurata, T.
|
|
|
15 |
1 |
p. 173-174
|
artikel
|
| 13 |
Epidermal growth factor receptor overexpression correlates with a poor prognosis in completely resected non-small-cell lung cancer
|
Selvaggi, G.
|
|
|
15 |
1 |
p. 28-32
|
artikel
|
| 14 |
Epirubicin–cyclophosphamide adjuvant chemotherapy plus tamoxifen administered concurrently versus sequentially: randomized phase III trial in postmenopausal node-positive breast cancer patients. A GEICAM 9401 study
|
Pico, C.
|
|
|
15 |
1 |
p. 79-87
|
artikel
|
| 15 |
Evidence for in vivo synergism between docetaxel and gemcitabine in patients with metastatic breast cancer
|
Alexopoulos, A.
|
|
|
15 |
1 |
p. 95-99
|
artikel
|
| 16 |
Her2-neu: a target in lung cancer?
|
Andre, F.
|
|
|
15 |
1 |
p. 3-4
|
artikel
|
| 17 |
HER-2 overexpression is an independent marker of poor prognosis of advanced primary ovarian carcinoma: a multicenter study of the GINECO group
|
Camilleri-Broët, S.
|
|
|
15 |
1 |
p. 104-112
|
artikel
|
| 18 |
Incidence and risk factors for central nervous system occurrencein elderly patients with diffuse large-B-cell lymphoma: influenceof rituximab
|
Feugier, P.
|
|
|
15 |
1 |
p. 129-133
|
artikel
|
| 19 |
Increased levels of viable circulating endothelial cells are an indicator of progressive disease in cancer patients
|
Beerepoot, L.V.
|
|
|
15 |
1 |
p. 139-145
|
artikel
|
| 20 |
Indolent lymphoma: the pathologist’s viewpoint
|
Pileri, S.A.
|
|
|
15 |
1 |
p. 12-18
|
artikel
|
| 21 |
INK4/ARF germline alterations in pancreatic cancer patients
|
Ghiorzo, P.
|
|
|
15 |
1 |
p. 70-78
|
artikel
|
| 22 |
In this issue
|
|
|
|
15 |
1 |
p. iii
|
artikel
|
| 23 |
Intravenous ibandronate reduces the incidence of skeletal complications in patients with breast cancer and bone metastases
|
Body, J.-J.
|
|
|
15 |
1 |
p. 180
|
artikel
|
| 24 |
Is there still a role for neoadjuvant chemotherapy in head and neck cancer?
|
Licitra, L.
|
|
|
15 |
1 |
p. 7-11
|
artikel
|
| 25 |
Lack of correlation between immunohistochemical expression of E2F-1, thymidylate synthase expression and clinical response to5-fluorouracil in advanced colorectal cancer
|
Belvedere, O.
|
|
|
15 |
1 |
p. 55-58
|
artikel
|
| 26 |
Long-term survival in a phase III, randomised study of topotecan versus paclitaxel in advanced epithelial ovarian carcinoma
|
ten Bokkel Huinink, W.
|
|
|
15 |
1 |
p. 100-103
|
artikel
|
| 27 |
Pharmacokinetic analysis of combination chemotherapy with carboplatin and etoposide in small-cell lung cancer patients undergoing hemodialysis
|
Inoue, A.
|
|
|
15 |
1 |
p. 51-54
|
artikel
|
| 28 |
Phase II study of irinotecan and 5-fluorouracil/leucovorin in patients with primary refractory or relapsed advanced oesophageal and gastric carcinoma
|
Assersohn, L.
|
|
|
15 |
1 |
p. 64-69
|
artikel
|
| 29 |
Primary treatment of multiple myeloma with thalidomide, vincristine, liposomal doxorubicin and dexamethasone(T-VAD doxil): a phase II multicenter study
|
Zervas, K.
|
|
|
15 |
1 |
p. 134-138
|
artikel
|
| 30 |
Randomised, multicentre phase II study assessing two doses of docetaxel (75 or 100 mg/m2) as second-line monotherapy fornon-small-cell lung cancer
|
Quoix, E.
|
|
|
15 |
1 |
p. 38-44
|
artikel
|
| 31 |
Randomized phase II trial of gemcitabine–cisplatin with or without trastuzumab in HER2-positive non-small-cell lung cancer
|
Gatzemeier, U.
|
|
|
15 |
1 |
p. 19-27
|
artikel
|
| 32 |
Renal tubular damage in rasburicase: risks of alkalinisation
|
van den Berg, H.
|
|
|
15 |
1 |
p. 175-176
|
artikel
|
| 33 |
Reply to “Letter to the Editor on ‘Vinorelbine, methotrexate and fluorouracil (VMF) as first line therapy in metastatic breast cancer: a randomised phase II trial’”, by B. Isik and K. Altundag (Ann Oncol 2004; 15: 175)
|
Blomqvist, C.
|
|
|
15 |
1 |
p. 175
|
artikel
|
| 34 |
Survival data and prognostic factors seen in Pakistani patients with esophageal cancer
|
Alidina, A.
|
|
|
15 |
1 |
p. 118-122
|
artikel
|
| 35 |
Table of Contents
|
|
|
|
15 |
1 |
p. i-ii
|
artikel
|
| 36 |
The impact of sentinel node biopsy and axillary staging strategy on hospital costs
|
Rönkä, R.
|
|
|
15 |
1 |
p. 88-94
|
artikel
|
| 37 |
VEPEMB in elderly Hodgkin’s lymphoma patients. Results from an Intergruppo Italiano Linfomi (IIL) study
|
Levis, A.
|
|
|
15 |
1 |
p. 123-128
|
artikel
|
| 38 |
Vinorelbine, methotrexate and fluorouracil (VMF) as first-line therapy in metastatic breast cancer: significance of the time between initiation of adjuvant therapy and of therapy for metastatic breast cancer
|
Isik, B.
|
|
|
15 |
1 |
p. 175
|
artikel
|
Tijdschrift beschrijving